Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-01-08

FDA Approved: TELMISARTAN AND AMLODIPINE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' telmisartan and amlodipine fixed-dose combination under an Original ANDA (ANDA201586).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Amlodipine (Telmisartan and Amlodipine)

Snippet

ORIG AP for TELMISARTAN AND AMLODIPINE (TELMISARTAN AND AMLODIPINE)